Lupin (LUPIN) Share Price Falls 2.02% as Large Cap Healthcare Stock Traded Near Day Low
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Lupin Share Price fell today, with Lupin last traded at Rs 1,966.60, down 2.02% from the previous close of Rs 2,007.10. The company’s market capitalisation stood at Rs 93,058.51 crore, keeping it within the Large Cap category. The move matters because the Lupin Share Price is being watched not only for the day’s decline but also for how it sits within a Healthcare business that carries a P/E of 16.6, ROE of 27.11% and ROCE of 28.86%. According to latest Univest figures, the Lupin Share Price event is clear even though no company-specific catalyst is established. For readers tracking Lupin Share Price Today, the current move, valuation and sector context are the main facts available at this point.
The latest Univest data shows a price event, a sharp intraday range and a valuation profile that gives the Lupin Share Price today a broader context than the percentage move alone. Investors following Lupin Stock News can focus on the numbers first, then compare them with the Healthcare industry benchmark and peers. As of 08 October 2026 at 12:52:50 PM IST, the Lupin Share Price had already touched the day’s low, which keeps the session’s price action in sharp focus.
Lupin (LUPIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,966.6 |
| Previous Close | Rs 2,007.1 |
| Today's Move | -Rs 40.50 (-2.02%) |
| Open | Rs 2,015.05 |
| High | Rs 2,020.7 |
| Low | Rs 1,966.6 |
| Market Capitalisation | Rs 93,058.51 crore |
| Market Cap Category | Large Cap |
Lupin Share Price Today reflected a clear decline from the previous close. Lupin opened at Rs 2,015.05, touched a high of Rs 2,020.70 and a low of Rs 1,966.60, before last trading at Rs 1,966.60. That places the Lupin Share Price below the previous close by Rs 40.50, or 2.02%. The stock therefore spent the observed move below the opening level and at the lower end of the day’s range. For a Large Cap company, such a move is relevant because the market capitalisation remains sizeable at Rs 93,058.51 crore, and the Lupin Share Price continues to sit within a company profile that investors often assess through both price action and fundamentals. Lupin Share Price Live checks are useful here because the chartless facts still show the session’s direction plainly. The Lupin Share Price today is a reminder that one session can reset near-term sentiment without changing the underlying business context.
In Lupin Share Price analysis, the key numbers are simple and factual: opening price, intraday high, intraday low, previous close and the final traded level observed so far in the session. That is enough to explain the Lupin Share Price Fall without adding anything speculative. The stock’s Large Cap label and market capitalisation make the decline noteworthy for Lupin Share Price News Today readers, especially when the move is compared with its valuation and profitability metrics. From here, the Lupin Share Price discussion naturally moves to fundamentals.
Lupin (LUPIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 93,058.51 crore |
| P/E Ratio | 16.6x |
| P/B Ratio | 3.86x |
| ROE | 27.11% |
| ROCE | 28.86% |
| EPS | Rs 120.9 |
| Book Value Per Share | Rs 520.48 |
| Dividend Yield | 0.9% |
Lupin (LUPIN) fundamental metrics show P/E 16.6x, P/B 3.86x, ROE 27.11%, ROCE 28.86%. Taken on their own, these numbers offer context rather than a trading signal.
Lupin has a market capitalisation of Rs 93,058.51 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.6x, P/B at 3.86x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 120.9, book value per share of Rs 520.48, dividend yield of 0.9%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 16.6x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 3.86x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 27.11% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 28.86% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 93,058.51 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Lupin (LUPIN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Lupin (LUPIN) has a P/E ratio of 16.6x, which is below the benchmark median of 31.87x, a difference of -47.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Lupin (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.61%, a difference of +133.51%. Lupin (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.46%, a difference of +114.41%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Lupin (LUPIN) has a P/E ratio of 16.6x compared with the displayed peer median of 82.14x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.11% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lupin (LUPIN) has a market capitalisation of Rs 93,058.51 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Lupin
- The Lupin Share Price fell 2.02% and last traded at Rs 1,966.60, which makes the latest session relevant for price action tracking.
- Large Cap status and Rs 93,058.51 crore market capitalisation keep the Lupin Share Price in a significant company-size bracket.
- P/E of 16.6 is below the same-industry median and average, giving the Lupin Share Price a lower earnings multiple than many peers.
- ROE of 27.11% and ROCE of 28.86% remain above the sector benchmark, which adds context to Lupin Share Price analysis.
- EPS of Rs 120.9, book value of Rs 520.48 and dividend yield of 0.9% give Lupin Share Price Today a clear fundamental frame.
About Lupin
Lupin operates in Healthcare, within the Pharmaceuticals & Drugs industry. The business context used here is the listed company’s sector and industry classification, along with the financial profile visible in the current figures. For Lupin Share Price readers, the company belongs to a Large Cap pharmaceutical name with a sizeable market capitalisation and a return profile that is stronger than the industry benchmark in ROE and ROCE. That combination is why Lupin Stock News often attracts attention from investors who compare valuation, earnings power and company size together rather than in isolation. The Lupin Share Price today can therefore be read as one part of a broader business and market profile.
Track Lupin Share Price on Univest
Use Lupin (LUPIN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Lupin Share Price on Univest for live share price updates, valuation ratios, 52-week levels and market insights in one place. Univest also helps you follow Lupin Share Price Today, Lupin Share Price News and Lupin Stock Analysis with a clean view of price action, fundamentals and sector comparison. If you want to monitor the Lupin Share Price alongside peer metrics and company ratios, Univest keeps those facts together for quick reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Lupin Share Price falling today?
Ans. Lupin Share Price fell 2.02% to Rs 1,966.60 from the previous close of Rs 2,007.10. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is Lupin Share Price Today?
Ans. Lupin Share Price Today was Rs 1,966.60 at the latest observation. The stock was down Rs 40.50, and the day’s range stretched from Rs 1,966.60 to Rs 2,020.70 after opening at Rs 2,015.05.
Is Lupin a Large Cap stock?
Ans. Yes, Lupin is a Large Cap stock in this article’s classification. Its market capitalisation stood at Rs 93,058.51 crore, which places the Lupin Share Price in a sizeable company bracket within Healthcare.
What does Lupin’s valuation show?
Ans. Lupin’s P/E is 16.6 and P/B is 3.86. The P/E is below the same-industry median and average, while ROE of 27.11% and ROCE of 28.86% show strong return metrics alongside the Lupin Share Price.
How do Lupin’s returns compare with the industry?
Ans. Lupin’s ROE of 27.11% and ROCE of 28.86% are above the same-industry median and average. That gives the Lupin Share Price a stronger profitability backdrop than many Healthcare peers in the benchmark set.
What are Lupin’s EPS and book value?
Ans. Lupin’s EPS is Rs 120.9 and book value is Rs 520.48 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share at the current Lupin Share Price.
What is Lupin’s dividend yield?
Ans. Lupin’s dividend yield is 0.9%. It is a historical payout measure linked to the current Lupin Share Price, and it adds a small income context to the stock’s broader valuation picture.
How does Lupin compare with peers on P/E?
Ans. Lupin’s P/E of 16.6 is lower than Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Mankind Pharma and Dr. Reddy’s Laboratories in the peer set shown with the Lupin Share Price.
Where can investors track Lupin Share Price live?
Ans. Investors can track Lupin Share Price on Univest for live updates, valuation ratios, sector context and 52-week levels. That keeps Lupin Share Price Today, Lupin Share Price News and company fundamentals in one place.
